NEW YORK, July 31, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Finisar Corporation
(NASDAQ:FNSR), Albireo Pharma, Inc. (NASDAQ:ALBO), Corporate Office Properties Trust (NYSE:OFC), Ocean Power Technologies, Inc.
(NASDAQ:OPTT), Depomed, Inc. (NASDAQ:DEPO), and Potbelly Corporation (NASDAQ:PBPB), including updated fundamental summaries,
consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
FNSR DOWNLOAD: http://Fundamental-Markets.com/register/?so=FNSR
ALBO DOWNLOAD: http://Fundamental-Markets.com/register/?so=ALBO
OFC DOWNLOAD: http://Fundamental-Markets.com/register/?so=OFC
OPTT DOWNLOAD: http://Fundamental-Markets.com/register/?so=OPTT
DEPO DOWNLOAD: http://Fundamental-Markets.com/register/?so=DEPO
PBPB DOWNLOAD: http://Fundamental-Markets.com/register/?so=PBPB
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine
Finisar Corporation (NASDAQ:FNSR), Albireo Pharma, Inc. (NASDAQ:ALBO), Corporate Office Properties Trust (NYSE:OFC), Ocean Power
Technologies, Inc. (NASDAQ:OPTT), Depomed, Inc. (NASDAQ:DEPO), and Potbelly Corporation (NASDAQ:PBPB) on a fundamental level and
outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management
discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's
readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed July 27th, 2018.
Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
FINISAR CORPORATION (FNSR) REPORT OVERVIEW
Finisar's Recent Financial Performance
For the three months ended April 30th, 2018 vs April 30th, 2017, Finisar reported revenue of $310.07MM vs
$357.53MM (down 13.27%) and basic earnings per share -$0.16 vs $1.18. For the twelve months ended April 30th, 2018 vs April 30th,
2017, Finisar reported revenue of $1,316.48MM vs $1,449.30MM (down 9.16%) and basic earnings per share -$0.42 vs $2.26. Finisar is
expected to report earnings on September 6th, 2018. The report will be for the fiscal period ending July 31st, 2018. The reported
EPS for the same quarter last year was $0.28. The estimated EPS forecast for the next fiscal year is $0.96 and is expected to
report on June 13th, 2019.
To read the full Finisar Corporation (FNSR) report, download it here: http://Fundamental-Markets.com/register/?so=FNSR
-----------------------------------------
ALBIREO PHARMA, INC. (ALBO) REPORT OVERVIEW
Albireo Pharma's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Albireo Pharma reported revenue of $11.20MM vs
$0.00MM and basic earnings per share -$0.15 vs -$1.06. For the twelve months ended December 31st, 2017 vs December 31st, 2016,
Albireo Pharma reported revenue of $0.00MM vs $11.36MM and basic earnings per share -$3.12 vs -$13.19. Albireo Pharma is expected
to report earnings on August 20th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the
same quarter last year was -$0.86. The estimated EPS forecast for the next fiscal year is -$3.97 and is expected to report on March
21st, 2019.
To read the full Albireo Pharma, Inc. (ALBO) report, download it here: http://Fundamental-Markets.com/register/?so=ALBO
-----------------------------------------
CORPORATE OFFICE PROPERTIES TRUST (OFC) REPORT OVERVIEW
Corporate Office Properties Trust's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Corporate Office Properties Trust reported
revenue of $155.48MM vs $139.80MM (up 11.21%) and basic earnings per share $0.17 vs $0.18 (down 5.56%). For the twelve months ended
December 31st, 2017 vs December 31st, 2016, Corporate Office Properties Trust reported revenue of $612.82MM vs $574.33MM (up 6.70%)
and basic earnings per share $0.57 vs -$0.03. Corporate Office Properties Trust is expected to report earnings on October 25th,
2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was
$0.53. The estimated EPS forecast for the next fiscal year is $2.09 and is expected to report on February 14th, 2019.
To read the full Corporate Office Properties Trust (OFC) report, download it here: http://Fundamental-Markets.com/register/?so=OFC
-----------------------------------------
OCEAN POWER TECHNOLOGIES, INC. (OPTT) REPORT OVERVIEW
Ocean Power Technologies' Recent Financial Performance
For the three months ended April 30th, 2018 vs April 30th, 2017, Ocean Power Technologies reported revenue of
$0.22MM vs $0.25MM (down 11.20%) and basic earnings per share -$0.15 vs $0.11. For the twelve months ended April 30th, 2018 vs
April 30th, 2017, Ocean Power Technologies reported revenue of $0.51MM vs $0.84MM (down 39.38%) and basic earnings per share -$0.66
vs -$2.23. Ocean Power Technologies is expected to report earnings on September 6th, 2018. The report will be for the fiscal period
ending July 31st, 2018.
To read the full Ocean Power Technologies, Inc. (OPTT) report, download it here: http://Fundamental-Markets.com/register/?so=OPTT
-----------------------------------------
DEPOMED, INC. (DEPO) REPORT OVERVIEW
Depomed's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Depomed reported revenue of $128.40MM vs
$90.45MM (up 41.97%) and basic earnings per share $0.53 vs -$0.43. For the twelve months ended December 31st, 2017 vs December
31st, 2016, Depomed reported revenue of $380.72MM vs $455.90MM (down 16.49%) and basic earnings per share -$1.63 vs -$1.45. Depomed
is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported
EPS for the same quarter last year was -$0.43. The estimated EPS forecast for the next fiscal year is -$0.69 and is expected to
report on February 26th, 2019.
To read the full Depomed, Inc. (DEPO) report, download it here: http://Fundamental-Markets.com/register/?so=DEPO
-----------------------------------------
POTBELLY CORPORATION (PBPB) REPORT OVERVIEW
Potbelly's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Potbelly reported revenue of $102.92MM vs
$101.70MM (up 1.20%) and basic earnings per share -$0.09 vs $0.03. For the twelve months ended December 31st, 2017 vs December
31st, 2016, Potbelly reported revenue of $428.11MM vs $407.13MM (up 5.15%) and basic earnings per share -$0.28 vs $0.32. Potbelly
is expected to report earnings on August 7th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported
EPS for the same quarter last year was $0.11. The estimated EPS forecast for the next fiscal year is $0.44 and is expected to
report on February 22nd, 2019.
To read the full Potbelly Corporation (PBPB) report, download it here: http://Fundamental-Markets.com/register/?so=PBPB
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a
partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory
Authority, Inc.
